Skip to Main Content

Clinical & Payment Policies

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules.  They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies.  Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information. 

All policies found in the Arkansas Total Care Clinical Policy Manual apply to Arkansas Total Care members. Policies in the Arkansas Total Care Clinical Policy Manual may have either a Arkansas Total Care or a “Centene” heading.  Arkansas Total Care utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Arkansas Total Care clinical policy does not exist.  InterQual is a nationally recognized evidence-based decision support tool.  You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Arkansas Total Care. In addition, Arkansas Total Care may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual® criteria is payable by Arkansas Total Care. 

If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.

Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding.  They are used to help identify whether health care services are correctly coded for reimbursement.  Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for  physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.

All policies found in the Arkansas Total Care Payment Policy Manual apply with respect to Arkansas Total Care members. Policies in the Arkansas Total Care Payment Policy Manual may have either a Arkansas Total Care or a “Centene” heading.  In addition, Arkansas Total Care may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Arkansas Total Care. 

Arkansas Total Care Policies

Policy Title Policy Number Effective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF) CP.MP.157 March 1, 2021
AbobotulinumtoxinA (Dysport) (PDF) CP.PHAR.230 November 1, 2020
Acupuncture (PDF) CP.MP.92 October 1, 2021
ADHD Assessment and Treatment (PDF) CP.MP.124 October 1, 2021
Ado-trastuzumab (Kadcyla) (PDF) CP.PHAR.229 June 1, 2021
Aducanumab (Aduhelm) (PDF) CP.PHAR.468 December 1, 2021
Adult Rehabilitative Day Service (Psychosocial Rehabilitation Services)(PDF) CP.BH.AR.1800 March 1, 2019
Afamelanotide (Scenesse) (PDF) CP.PHAR.444 March 1, 2021
Aflibercept (Eylea) (PDF) CP.PHAR.184 December 1, 2021
Agalsidase beta (Fabrazyme) (PDF) CP.PHAR.158 August 1, 2021 
Air Ambulance (PDF) CP.MP.175 October 1, 2021
Alemtuzumab (Lemtrada) (PDF) CP.PHAR.243 June 1, 2021
Alglucosidase (Lumizyme) (PDF) CP.PHAR.160 June 1, 2021
Allogenic Hematopoietic Cell Transplants for Sickle Cell (PDF) CP.MP.108 January 1, 2021
Allergy Testing and Therapy (PDF) CP.MP.100 June 1, 2021
Ambulatory EEG (PDF) CP.MP.96 September 1, 2021
Amisulpride (Barhemsys) (PDF) CP.PMN.236 November 1, 2021
Amivantamab-vmjw (Rybrevant) (PDF) CP.PHAR.544 October 1, 2021
Antithrombin III (Thrombate III, Atryn) (PDF) CP.MP.179 December 1, 2020
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) CP.PHAR.506 December 1, 2020
Apalutamide (Erleada) (PDF) CP.PHAR.376 August 1, 2021 
Applied Behavioral Analysis for Autism (PDF) CP.BH.104 August 1, 2021
Articular Cartilage Defect Repairs (PDF) CP.MP.26 April 1, 2021
Assistive Reproductive Technology (PDF) CP.MP.55 May 1, 2021
Atezolizumab (Tecentriq) (PDF) CP.PHAR.235 March 1, 2021
Avelumab (Bavencio) (PDF) CP.PHAR.333 May 1, 2021
axicabtagene ciloleucel (Yescarta®) (PDF) CP.PHAR.362 June 1, 2021
Azacitidine (Vidaza) (PDF) CP.PHAR.387 December 1, 2020
Balloon Sinus Ostial Dilation (PDF) CP.MP.119 November 1, 2020
Bariatric Surgery (PDF) CP.MP.37 November 1, 2021
Behavioral Assistance (Therapeutic Behavioral Services) (PDF) CP.BH.AR.1900 March 1, 2019
Belantamab mafodotin (Blenrep) (PDF) CP.PHAR.469 June 1, 2021
Belatacept (Nulojix) (PDF) CP.PHAR.201 December 1, 2020
Belinostat (Beleodaq) (PDF) CP.PHAR.311 December 1, 2020
Bendamustine (Bendeka, Treanda) (PDF) CP.PHAR.307 December 1, 2020
Betibeglogene autotemcel (PDF) CP.PHAR.545 October 1, 2021
Bevacizumab (Avastin, Mvasi, Zirabev) (PDF) CP.PHAR.93 August 2, 2021
Bimatoprost Implant (Durysta)(PDF) CP.PHAR.486 June 1, 2021
Biofeedback (PDF) CP.MP.168 July 1, 2021
Blinatumomab (Blincyto) (PDF) CP.PHAR.312 November 1, 2021
Bone-Anchored Hearing Aid (PDF) CP.MP.93 October 1, 2021
Brentuximab Vedotin (Adcetris) (PDF) CP.PHAR.303 July 1, 2021
Brexanolone (Zulresso) (PDF) CP.PHAR.417 June 1, 2021
Brexucabtagene Autoleucel (Tecartus) (PDF) CP.PHAR.472 July 1, 2021
Brolucizumab-dbll (Beovu) (PDF) CP.PHAR.445  May 1, 2021
Bronchial Thermoplasty (PDF) CP.MP.110 June 1, 2021
Burn Surgery (PDF) CP.MP.186 October 1, 2021
cabazitaxel (Jevtana®) (PDF) CP.PHAR.316 August 1, 2021 
Canakinumab (Ilaris) (PDF) CP.PHAR.246 August 1, 2021 
Cardiac Biomarker Testing for Acute MI (PDF) CP.MP.156 March 1, 2021
Carbetocin (PDF) CP.PHAR.546 October 1, 2021
Carfilzomib (Kyprolis) (PDF) CP.PHAR.309 December 1, 2020
Casimersen (Amondys 45) (PDF) CP.PHAR.470 June 1, 2021
Caudal or Interlaminar Epidural Steroid Injections (PDF) CP.MP.164 December 1, 2021
Cemiplimab-rwlc (Libtayo) (PDF) CP.PHAR.397 June 1, 2021
Cerliponase alfa (Brineura) (PDF) CP.PHAR.338 November 1, 2021
Cetuximab (Erbitux) (PDF) CP.PHAR.317 December 1, 2020
Child and Youth Support Services (PDF) CP.BH.AR.1700 March 1, 2019
Clinical Policy: Rituximab (Rituxan), Rituxan/Hyaluronidase (Rituxan Hycela) (PDF) CP.PHAR.260 October 1, 2021 
Clinical Trials (PDF) CP.MP.94 August 1, 2021
Cochlear Implant Replacements (PDF) CP.MP.14 September 1, 2020
Collagenase (Xiaflex) (PDF) CP.PHAR.82 November 1, 2021
Continuous Insulin Delivery Systems (V-Go, Omnipod) (PDF) CP.PHAR.505 December 1, 2020
Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (PDF) CP.PHAR.385 July 1, 2021
Cosmetic Reconstructive Surgery (PDF) CP.MP.31 January 1, 2022 - NEW
Cosyntropin (Cortrosyn) (PDF) CP.PHAR.203 March 1, 2021 
Crisis Intervention (PDF) CP.BH.AR.1500 March 1, 2019

Crizanlizumab-tmca (Adakveo) (PDF)

CP.PHAR.449 June 1, 2020
Cytomegalovirus Immune Globulin (Cytogam) (PDF) CP.PHAR.277 November 1, 2021
Daptomycin (Cubicin, Cubicin RF) (PDF) CP.PHAR.351 November 1, 2021
Daratumumab (Darzalex) (PDF) CP.PHAR.310 July 1, 2021
Daunorubicin-cytarabine (Vyxeos) (PDF) CP.PHAR.352 July 1, 2021
Deep Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder (PDF) CP.BH.201 June 1, 2021
Deferoxamine (Desferal) (PDF) CP.PHAR.146 July 1, 2021
Dental Anesthesia (PDF) CP.MP.61 May 1, 2021
Dexrazoxane (Zinecard, Totect) (PDF) CP.PHAR.418 June 1, 2021
Diaphragmatic/Phrenic Nerve Stimulation (PDF) CP.MP.203 May 1, 2021
Digital Analysis of EEGs (PDF) CP.MP.105 March 1, 2021
Disc Decompression Procedures (PDF) CP.MP.114 July 1, 2021
Discography (PDF) CP.MP.115 August 1, 2021
Donor lymphocyte infusion (PDF) CP.MP.101 December 1, 2020
Dostarlimab-gxly (Jemperli) (PDF) CP.PHAR.540 November 1, 2021
DNA Analysis of Stool (PDF) CP.MP.125 August 1, 2021
Drugs of Abuse: Presumptive Testing (PDF) CP.MP.208 December 1, 2021
Durable Medical Equipment (DME) (PDF) CP.MP.107 January 1, 2022 - NEW
Durvalumab (Imfinzi) (PDF) CP.PHAR.339 August 1, 2021 
Ecallantide (Kalbitor) (PDF) CP.PHAR.177 November 1, 2021
Eculizumab (Soliris) (PDF) CP.PHAR.97 May 1, 2021
Edaravone (Radicava) (PDF) CP.PHAR.343 June 1, 2021
EEG in Evaluation of Headache (PDF) CP.MP.155 July 1, 2021
Elapegademase-lvlr (Revcovi) (PDF) CP.PHAR.419 August 1, 2021 
Electric Tumor Treatment Fields (PDF) CP.MP.145 May 1, 2021
Electromyography and Nerve Conduction Studies (PDF) CP.MP.211 September 1, 2021
Elosulfase alfa (Vimizim) (PDF) CP.PHAR.162 June 1, 2021
Elotuzumab (Empliciti) (PDF) CP.PHAR.308 December 1, 2020
Endometrial Ablation (PDF) CP.MP.106 September 1, 2021
Enfortumab Vedotin-ejfv (Padcev) (PDF) CP.PHAR.455 March 1, 2021
Enfuvirtide (Fuzeon) (PDF) CP.PHAR.41 November 1, 2021
Eptinezumab-jjmr (Vyepti) (PDF) CP.PHAR.489 December 1, 2021
Eribulin mesylate (Halaven) (PDF) CP.PHAR.318 March 1, 2021
Erwinia Asparaginase (Erwinaze) (PDF) CP.PHAR.301 March 1, 2021
Essure Removal (PDF) CP.MP.131 December 1, 2020
Etelcalcetide (Parsabiv) (PDF) CP.PHAR.379 July 1, 2021
Eteplirsen  (Exondys 51) (PDF) CP.PHAR.288 July 1, 2021
Evinacumab-dgnb (Evkeeza) (PDF) CP.PHAR.511 August 1, 2021 
Evoked Potentials (PDF) CP.MP.134 October 1, 2021
Experimental Technologies (PDF) CP.MP.36 June 1, 2021
Facet Joint Interventions (PDF) CP.MP.171 September 1, 2021
Factor VIII (Human Recombinant) (PDF) CP.PHAR.215  April 1, 2021
Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF) CP.PHAR.216 May 1, 2021
Factor IX (Human, Recombinant) (PDF) CP.PHAR.218 December 1, 2020
Factor XIII, Human (Corifact®) (PDF) CP.PHAR.221 March 1, 2021
Factor XIII A-Subunit, Recombinant (Tretten®) CP.PHAR.222 March 1, 2021
Family Support Partners (PDF) CP.BH.AR.1600 March 1, 2019
Fam-trastuzumab Deruxtecan-nxki (Enhertu) (PDF) CP.PHAR.456 March 1, 2021
Fecal incontinence treatments (PDF) CP.MP.137 September 1, 2021
Ferric Derisomaltose (Monoferric)(PDF) CP.PHAR.480 August 1, 2021 
Ferriscan R2-MRI (PDF) CP.MP.53 December 1, 2020
Fertility Preservation (PDF) CP.MP.130 June 1, 2021
Fetal surgery in utero for prenatally diagnosed malformations (PDF) CP.MP.129 December 1, 2021
Fibrinogen concentrate (human) (Fibryga, RiaSTAP) (PDF) CP.PHAR.526 June 1, 2021
Fractional Exhaled Nitric Oxide(PDF) CP.MP.103 January 1, 2021
Fulvestrant (Faslodex Injection) (PDF) CP.PHAR.424 July 1, 2021
Galsulfase (Naglazyme) (PDF) CP.PHAR.161 June 1, 2021
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF) CP.MP.209 January 1, 2022 - NEW
Gemtuzumab (Mylotarg) (PDF) CP.PHAR.358 December 1, 2020
Gender reassignment surgery (PDF) CP.MP.95 September 1, 2021
Genetic Testing (PDF) CP.MP.89 June 1, 2021 
Givosiran (Givlaari) (PDF) CP.PHAR.457 March 1, 2021
Golodirsen (Vyondys 53) (PDF) CP.PHAR.453 July 1, 2021
Group Psychotherapy (PDF) CP.BH.AR.600 March 1, 2019
Heart-Lung Transplant (PDF) CP.MP.132 October 1, 2021
Helicobacter Pylori Serology Testing (PDF) CP.MP.153 December 1, 2020
Holter Monitors (PDF) CP.MP.113 June 1, 2021
Home Birth (PDF) CP.MP.136 February 1, 2021
Home Phototherapy for Neonatal Hyperbilirubinemia (PDF) CP.MP.150 March 1, 2021
Homocysteine Testing (PDF) CP.MP.121 July 1, 2021
Hospice Clinical Coverage (PDF) CP.MP.54 September 1, 2021
Hyaluronate derivatives (PDF) CP.PHAR.05 March 1, 2021
Hyperemesis Gravidarum Treatment (PDF) CP.MP.34 July 1, 2021
Hyperhidrosis Treatments (PDF) CP.MP.62 March 1, 2021
ibalizumab-uiyk (Trogarzo) (PDF) CP.PHAR.378 June 1, 2021
Icatibant (Firazyr®) (PDF) CP.PHAR.178 October 1, 2021
Idursulfase (Elaprase) (PDF) CP.PHAR.156 June 1, 2021
Imiglucerase (Cerezyme) (PDF) CP.PHAR.154 June 1, 2021
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF) CP.MP.180 January 1, 2021
Implantable Intrathecal Pain Pump (PDF) CP.MP.173 March 1, 2021
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF) CP.MP.160 June 1, 2021
IncobotulinumtoxinA (Xeomin) (PDF) CP.PHAR.231 June 1, 2021
Individual/Group Pharmacologic Counseling by RN  (Medication Training and Support) (PDF) CP.BH.AR.1200 March 1, 2019
Inebilizumab (PDF) CP.PHAR.458 March 1, 2021
Infliximab (Remicade, Inflectra, Renflexis) (PDF) CP.PHAR.254 October 1, 2021 
Inhaled Nitric Oxide (PDF) CP.MP.87 December 1, 2021
Inotuzumab Ozogamicin (Besponsa) (PDF) CP.PHAR.359 December 1, 2020
Intensity Modulated Radiation Therapy (PDF) CP.MP.69 February 1, 2021
Interpretation of Diagnosis (PDF) CP.BH.AR.800 March 1, 2019
Intestinal & Multivisceral Transplant (PDF) CP.MP.58 October 1, 2021
Intradiscal Steroid Injections (PDF) CP.MP.167 October 1, 2021
Iobenguane I-131 (Azedra) (PDF) CP.PHAR.459 March 1, 2021
Ipilimumab (Yervoy) (PDF) CP.PHAR.319 August 1, 2021 
Irinotecan Liposome (Onivyde) (PDF) CP.PHAR.304 March 1, 2021
Isatuximab-irfc (Sarclisa)(PDF) CP.PHAR.482 June 1, 2021
Lanadelumab-fylo (Takhzyro) (PDF) CP.PHAR.396 November 1, 2021
Lanreotide (Somatuline Depot) (PDF) CP.PHAR.391 December 1, 2020
Laronidase (Aldurazyme) (PDF) CP.PHAR.152 August 1, 2021 
Laser Skin Treatment (PDF) CP.MP.123 August 1, 2021
Levoleucovorin (Fusilev, Khapzory) (PDF) CP.PHAR.151 December 1, 2020
Lisocabtagene maraleucel (Breyanzi) (PDF) CP.PHAR.483 June 1, 2021
Loncastuximab tesirine-lpyl (Zynlonta) (PDF) CP.PHAR.539 November 1, 2021
Low-Frequency Ultrasound Wound Therapy (PDF) CP.MP.139 September 1, 2021
Lumasiran (Oxlumo) (PDF) CP.PHAR.473 October 1, 2021
Lung Transplantation (PDF) CP.MP.57 July 1, 2020
Lurbinectedin (Zepzelca) (PDF) CP.PHAR.500 July 1, 2021
Lutetium Lu 177 Dotatate (Lutathera) (PDF) CP.PHAR.384 July 1, 2021
Lysis of Epidural Lesions (PDF) CP.MP.116 July 1, 2021
Marital Family BH Counseling with Beneficiary Present (PDF) CP.BH.AR.400 March 1, 2019
Marital Family BH Counseling without Beneficiary Present (PDF) CP.BH.AR.300 March 1, 2019
Measure Serum 1,25 Vitamin D (PDF) CP.MP.152 December 1, 2020
Mecasermin (Increlex) (PDF) CP.PHAR.150 July 1, 2021
Mechanical Stretch Devices (PDF) CP.MP.144 June 1, 2021
Metreleptin (Myalept) (PDF) CP.PHAR.425 November 1, 2021
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) CP.PHAR.495 November 1, 2021
Mitoxantrone (Novantrone) (PDF) CP.PHAR.258 August 1, 2021 
Mometasone Furoate (Sinuva) (PDF) CP.PHAR.448 March 1, 2021
Multi-Family Behavioral Health Counseling (PDF) CP.BH.AR.500 March 1, 2019
Multiple Sleep Latency Testing (PDF) CP.MP.24 June 1, 2021
Nadofaragene Firadenovec (Instiladrin)(PDF) CP.PHAR.461 March 1, 2021
Natalizumab (Tysabri) (PDF) CP.PHAR.259 July 1, 2021
Neonatal Abstinence Syndrome Guidelines (PDF) CP.MP.86 October 1, 2020
Neonatal Sepsis Management Guidelines (PDF) CP.MP.85 December 1, 2021
Neurofeedback for Behavioral Health Disorders (PDF) CP.BH.300 August 1, 2021
Neuromuscular Electrical Stimulation (PDF) CP.MP.48 December 1, 2021
Netupitant and Palonosetron (Akynzeo) (PDF) CP.PMN.158 July 1, 2021
Nerve Blocks for Pain Management (PDF) CP.MP.170 January 1, 2021
NICU Apnea Bradycardia Guidelines (PDF) CP.MP.82 August 1, 2021
NICU Discharge Guidelines (PDF) CP.MP.81 November 1, 2021 
Nivolumab (Opdivo) (PDF) CP.PHAR.121   June 1, 2020
Non-Invasive Home Ventilator (PDF) CP.MP.184 October 1, 2021
Nonmyeloablative allogeneic stem cell transplant (PDF) CP.MP.141 April 1, 2021
nusinersen (Spinraza®) (PDF) CP.PHAR.327 July 1, 2021
OB Home Health Programs (PDF) CP.MP.91 May 1, 2021
Ocrelizumab (Ocrevus) (PDF) CP.PHAR.335 June 1, 2021
Ofatumumab (Arzerra, Kesimpta) (PDF) CP.PHAR.306 August 1, 2021 
Omecetaxine (Synribo) (PDF) CP.PHAR.108 August 1, 2021 
OnabotulinumtoxinA (Botox) (PDF) CP.PHAR.232 August 1, 2021 
Onasemnogene abeparvovec (Zolgensma) (PDF) CP.PHAR.421 June 1, 2021
Optic Nerve Decompression Surgery (PDF) CP.MP.128 October 1, 2021
Outpatient Cardiac Rehabilitation (PDF) CP.MP.176 July 1, 2021
Outpatient Testing for Drugs of Abuse (PDF) CP.MP.50 August 1, 2021
Oxygen Use and Concentrators (PDF) CP.MP.190 January 1, 2021
Ozanimod(PDF) CP.PHAR.462 June 1, 2021
Pancreas Transplantation (PDF) CP.MP.102 October 1, 2021
Panitumumab (Vectibix) (PDF) CP.PHAR.321 December 1, 2020
Panniculectomy (PDF) CP.MP.109 August 1, 2021 
Paricalcitol Injection (Zemplar) (PDF) CP.PHAR.270 October 1, 2021
Patisiran (Onpattro) (PDF) CP.PHAR.395 December 1, 2020
Peanut Allergen Powder-dnfp (Palforzia)(PDF) CP.PMN.220 March 1, 2021
Pediatric Heart Transplant (PDF) CP.MP.138 October 1, 2021
Pediatric Liver Transplant (PDF) CP.MP.120 October 1, 2021
Pediatric Oral Function Therapy (PDF) CP.MP.188 July 1, 2021
Peer Support (PDF) CP.BH.AR.1300 March 1, 2019
Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (PDF) CP.PHAR.353 December 1, 2020
Pegaptanib (Macugen) (PDF) CP.PHAR.185 March 1, 2021
Pegcetacoplan (Empaveli) (PDF) CP.PHAR.524 November 1, 2021
Pegvaliase-pqpz (Palynziq) (PDF) CP.PHAR.140 March 1, 2021
pembrolizumab (Keytruda®) (PDF) CP.PHAR.322 September 1, 2021
Pemetrexed (Alimta, Pemfexy) (PDF) CP.PHAR.368 May 1, 2021
Percutaneous LAAD Stroke Prevention (PDF) CP.MP.147 July 1, 2021
Pertuzumab (Perjeta) (PDF) CP.PHAR.227 August 1, 2021 
Pertuzumab-trastuzumab-hyaluronidase-zzxf (Phesgo) (PDF) CP.PHAR.501 July 1, 2021
Pharmacologic Management (PDF) CP.BH.AR.1000 March 1, 2019
Physical, Occupational, and Speech Therapy Services (PDF) CP.MP.49 August 1, 2021
Plerixafor (Mozobil) (PDF) CP.PHAR.323 November 1, 2021
Polatuzumab Vedotin-piiq (Polivy) (PDF) CP.PHAR.433 July 1, 2021
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF) CP.MP.181 October 1, 2021
Posterior Nerve Stimulation for Voiding Dysfunction (PDF) CP.MP.133 October 1, 2021
Post-Acute Care (PDF) CP.MP.213 January 1, 2021
Pralatrexate (Folotyn) (PDF) CP.PHAR.313 December 1, 2020
Psychiatric Diagnosis Evaluation (PDF) CP.BH.AR.100 March 1, 2019
Psychoeducation Services (PDF) CP.BH.AR.2100 March 1, 2019
Psychological Evaluation of Psych Testing (PDF) CP.BH.AR.900 March 1, 2019
Psychotherapy (PDF) CP.BH.AR.200 March 1, 2019
Radial Head Implant (PDF) CP.MP.148 July 1, 2021
Radiofrequency Ablation of Uterine Fibroids (PDF) CP.MP.187 June 1, 2021
Ramucirumab (Cyramza) (PDF) CP.PHAR.119  April 1, 2021
Ranibizumab (Lucentis) (PDF) CP.PHAR.186 March 1, 2021
Reduction Mammoplasty and Gynecomastia Surgery (PDF) CP.MP.51 September 1, 2021
Repair of Nasal Valve Compromise (PDF) CP.MP.210 October 1, 2021
Rilonacept (Arcalyst) (PDF) CP.PHAR.266 August 1, 2021 
RimabotulinumtoxinB (Myobloc) (PDF) CP.PHAR.233 June 1, 2021
Risdiplam (Evrysdi) (PDF) CP.PHAR.477 June 1, 2021
Romidepsin (Istodax) (PDF) CP.PHAR.314 December 1, 2020
Romiplostim (Nplate®) (PDF) CP.PHAR.179 March 1, 2021
Sacituzumab Govitecan-hziy (Trodelvy) (PDF) CP.PHAR.475 June 1, 2021
Sacroiliac Joint Fusion (PDF) CP.MP.126 August 1, 2021
Sacroiliac Joint Interventions (PDF) CP.MP.166 October 1, 2021
Sargramostim (Leukine) (PDF) CP.PHAR.295 July 1, 2021
Sclerotherapy (PDF) CP.MP.146 October 1, 2021
Sebelipase alfa (Kanuma) (PDF) CP.PHAR.159 June 1, 2021
Selective Dorsal Rhizotomy (PDF) CP.MP.174 May 1, 2021
Selective Nerve Root Blocks and Transforaminal Epidural (PDF) CP.MP.165 October 1, 2021
Sipuleucel-T (Provenge) (PDF) CP.PHAR.120 August 1, 2021 
Siltuximab (Sylvant) (PDF)  CP.PHAR.329 March 1, 2021
Skilled Nursing Facility Leveling (PDF) CP.MP.206 October 1, 2021
Skin Substitutes for Chronic Wounds (PDF) CP.MP.185 September 1, 2021
Sotrovimab (VIR-7831) (PDF) CP.PHAR.541 November 1, 2021
Spinal Cord Stimulation (PDF) CP.MP.117 September 1, 2021
Stereotactic Body Radiation Therapy (PDF) CP.MP.22 March , 2021
Substance Abuse Assessment (PDF) CP.BH.AR.1100 March 1, 2019
Supportive Employment (PDF) CP.BH.AR.2000 March 1, 2019
Supportive Housing (PDF) CP.BH.AR.1400 March 1, 2019
Tafasitamab-cxix (Monjuvi) (PDF) CP.PHAR.508 December 1, 2020
Taliglucerase alfa (Elelyso) (PDF) CP.PHAR.157 June 1, 2021
Talimogene laherparepvec (Imlygic) (PDF) CP.PHAR.542 November 1, 2021
Tandem Transplant (PDF) CP.MP.162 October 1, 2021
Temozolomide (Temodar) CP.PHAR.77 August 1, 2021 
Teprotumumab (Tepezza)(PDF) CP.PHAR.465 March 1, 2021
Testosterone (Testopel, Jatenzo) (PDF) CP.PHAR.354 December 1, 2020
Thymus Transplantation (PDF) CP.MP.189 August 1, 2021
Thyrotropin alfa (Thyrogen) (PDF) CP.PHAR.95 November 1, 2021
Tisagenlecleucel (Kymriah) (PDF) CP.PHAR.361 July 1, 2021
Topotecan (Hycamtin) (PDF) CP.PHAR.64 June 1, 2021
Total Artificial Heart (PDF) CP.MP.127 January 1, 2021
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF) CP.MP.163 September 1, 2021
Transcatheter closure of patent foramen ovale (PDF) CP.MP.151 January 1, 2021
Trastuzumab (Herceptin), Trastuzumab-dkst (Ogivri) (PDF) CP.PHAR.228 June 1, 2021
Treatment Plan (PDF) CP.BH.AR.700 March 1, 2019
Triamcinolone ER Injection (Zilretta) (PDF) CP.PHAR.371 June 1, 2021
Trigger Point Injections for Pain Management (PDF) CP.MP.169 October 1, 2021
Urinary Incontinence Devices and Treatments (PDF) CP.MP.142 May 1, 2021
Vagus Nerve Stimulation for Epilepsy (PDF) CP.MP.12 October 1, 2021
Valoctocogene Roxaparvovec(PDF) CP.PHAR.466 March 1, 2021
Valproate (Depacon) (PDF) CP.PHAR.429 November 1, 2021
Valrubicin (Valstar) (PDF) CP.PHAR.439 December 1, 2020
Vedolizumab (Entyvio) (PDF) CP.PHAR.265 October 1, 2021 
Velaglucerase alfa (VPRIV) (PDF) CP.PHAR.163 June 1, 2021
Ventricular Assist Devices (PDF) CP.MP.46 July 1, 2021
Verteporfin (Visudyne) (PDF) CP.PHAR.187 March 1, 2021
Vestronidase alfa-vjbk (Mepsevii) (PDF) CP.PHAR.374 June 1, 2021
Video Electroencephalographic (VEEG) Monitoring (PDF) CP.MP.177 October 1, 2020
Viltolarsen (Viltepso) (PDF) CP.PHAR.484 July 1, 2021
Wheelchair seating (PDF) CP.MP.99 September 1, 2021
Ziv-aflibercept (Zaltrap) (PDF) CP.PHAR.325 December 1, 2020
Zika Virus Testing (PDF) CP.MP.111 July 1, 2020
Zoledronic acid (PDF) CP.PHAR.59 March 1, 2021
Policy Title Policy Number Effective Date
3-Day Payment Window (PDF) CC.PP.500 July 1, 2014
Acupuncture (PDF) CP.MP.92 February 1, 2021
Add on Code Billed Without Primary Code (PDF) CC.PP.030 October 18, 2016
Aducanumab (Aduhelm) (PDF) CP.PHAR.468 December 1, 2021
Assistant Surgeon (PDF) CC.PP.029 February 7, 2017
Bevacizumab (PDF) CP.PHAR.93 September 1, 2021
Bilateral Procedures (PDF) CC.PP.037 February 7, 2017
Cerumen Removal (PDF) CC.PP.008 August 12, 2016
Clean Claims (PDF) CC.PP.021 October 18, 2016
Coding Overview (PDF) CC.PP.011 October 18, 2016
Cosmetic Procedures (PDF) CC.PP.024 October 18, 2016
Testing for Select Genitourinary Conditions (PDF) CP.MP.97 December 1, 2021
Distinct Procedural Modifiers (PDF) CC.PP.020 October 18, 2016
Duplicate Primary Code Billing (PDF) CC.PP.044 February 7, 2017
E&M Medical Decision-Making (PDF) CC.PP.051 July 25, 2017
EM Bundling Edits (PDF) CC.PP.010 August 12, 2016
EpiFix Wound Treatment (PDF) CP.MP.140 November 1, 2017
Fecal Calprotectin Assay (PDF) CP.MP.135 June 17, 2017
Global Maternity Billing (PDF) CC.PP.016 October 18, 2016
Hospital Visit Codes Billed with Labs (PDF) CC.PP.023 October 18, 2016
Inpatient Consultation (PDF) CC.PP.038 February 7, 2017
Inpatient Only Procedures (PDF) MP.PP.018 October 18, 2016
IV Hydration (PDF) CC.PP.012 October 18, 2016
Leveling of Care: Evaluation and Management Overcoding (PDF) CC.PP.066 March 15, 2021
Leveling of Emergency Room (PDF) CC.PP.053  January 1, 2019
Long Term Care Placement Criteria (PDF) CP.MP.71 June 1, 2021
Maximum Units (PDF) CC.PP.007 August 12, 2016
Mechanical Stretch Devices (PDF) CP.MP.144 November 1, 2017
Moderate Conscious Sedation (PDF) CC.PP.015 October 18, 2016
Modifier -25 clinical validation (PDF) CC.PP.013 October 18, 2016
Modifier -59 clinical validation (PDF) CC.PP.014 October 18, 2016
Modifier DOS Validation (PDF) CC.PP.034 October 18, 2016
Modifier to Procedure Code Validation (PDF) CC.PP.028 October 18, 2016
Monitored Anesthesia Care (PDF) CP.MP.161 December 15, 2018
Multiple CPT Code Replacement (PDF) CC.PP.033 October 18, 2016
Multiple Diagnostic Cardiovascular Procedure Payment Reduction (PDF) CC.PP.065 March 15, 2021
Multiple Procedure Reduction: Ophthalmology (PDF) CC.PP.069 March 15, 2021
Multiple Procedure Payment Reduction for Therapeutic Services (PDF) CC.PP.068 March 15, 2021
NCCI Unbundling (PDF) CC.PP.031 October 18, 2016
Never Paid Events (PDF) CC.PP.017 October 18, 2016
New Patient (PDF) CC.PP.036 February 7, 2017
Non-Obstetrical Pelvic and Transabdominal Ultrasound (PDF) CC.PP.061  March 15, 2021
Outpatient Consultation (PDF) CC.PP.039 February 7, 2017
Paclitaxel (PDF) CP.PHAR.176 May 16, 2016
Physician’s Consultation Services (PDF) CC.PP.054 September 1, 2018
Physician Visit Codes Billed with Labs (PDF) CC.PP.019 October 18, 2016
Place of Service Mismatch (PDF) CC.PP.063  December 15, 2018
Post-Operative Visits (PDF) CC.PP.042 February 7, 2017
Pre-Operative Visits (PDF) CC.PP.041 February 7, 2017
Problem Oriented Visits with Surgical Procedures (PDF) CC.PP.052 November 1, 2018
Professional Component (PDF) CC.PP.027 October 18, 2016
PROM Testing (PDF) CP.MP.149 August 1, 2021
Proton and Neutron Beam Therapy (PDF) CP.MP.70 April 1, 2021
Pulse Oximetry (PDF) CC.PP.025 October 18, 2016
Renal Hemodialysis (PDF) CC.PP.067 March 15, 2021
Robotic Surgery (PDF) CC.PP.050 November 1, 2017
Same Day Visits (PDF) CC.PP.040 February 7, 2017
Status "B" Bundled Services (PDF) CC.PP.046 February 7, 2017
Status P Bundled Services (PDF) CC.PP.049 June 17, 2017
Sickle Cell Disease Observation (PDF) CP.MP.88 September 11, 2021
Supplies Billed on Same Day As Surgery (PDF) CC.PP.032 October 18, 2016
Supportive Living (PDF) ARTC.PP.1000 July 20, 2020
Thyroid Testing in Pediatrics (PDF) CP.MP.154 December 1, 2020
Transcranial Magnetic Stimulation (PDF) CP.BH.200 June 1, 2021
Transgender Related Services (PDF) CC.PP.047 February 22, 2017
Ultrasound in Pregnancy (PDF) CP.MP.38 November 1, 2021
Unbundled Professional Services (PDF) CC.PP.043 April 6, 2017
Unbundled Surgical Procedures (PDF) CC.PP.045 April 6, 2017
Unlisted Procedure Codes (PDF) CC.PP.009 August 12, 2016
Urine Specimen Validity Testing (PDF) CC.PP.056 November 8, 2017
Urodynamic Testing (PDF) CP.MP.98 September 1, 2021
Wheelchair Accessories (PDF) CC.PP.502 August 12, 2016
Wireless Motility Capsule (PDF) CP.MP.143 March 1, 2021
 
Policy Title Policy Number Effective Date
Behavioral Health Covered Benefits and Services (PDF) CC.BH.UM.28 February 15, 2021
Behavioral Health Covered Benefits and Services - Attachment F (PDF) CC.BH.UM.28 Attachment F February 15, 2021